<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8042.36810 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 2/10/2022 12:21:37 PM -->
      <!-- iXBRL Library version: 1.0.8042.36816 -->
      <!-- iXBRL Service Job ID: 356ec292-d535-441c-8ade-9197aa3d4fa8 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:gbio="http://gbio.com/20220204" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityCentralIndexKey" id="Tc_U1iFJXjf7kqhkUWtQ7Faxg_1_1">0001733294</ix:nonNumeric><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:AmendmentFlag" id="Tc_yoF-ppBbkUWi8NYB17jr-w_2_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="gbio-20220204.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001733294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-04</xbrli:startDate><xbrli:endDate>2022-02-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10%;padding-right:10%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:5.75pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_34789f8e_d647_45ba_8d09_adbbc3f0a801"></a><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:5.0pt;margin-bottom:5pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:DocumentType" id="Narr_3vbYSWYee06ixlI2P945wg"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:5.0pt;margin-bottom:5pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">Date of report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_VhyqVIT_IkqwYqJXICi3Jg"><b style="font-weight:bold;">February&#160;4, 2022</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:5.0pt;margin-bottom:5pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:24pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityRegistrantName" id="Narr_bolwejccfUiIT3JknvhsyQ"><b style="font-weight:bold;">Generation Bio Co.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">(Exact Name of Registrant as Specified in Charter)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:5.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_d7252323_6c36_4a5e_af8e_656c9c3377cf"></a><a id="Tc_eRd-aFQM0kmg5W19mVh6pQ_1_0"></a><a id="Tc_rwACfec71Eu7DCqf7W0VkA_1_2"></a><a id="Tc_JlLn3_k3ckC_bgpT6s1Vtg_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:31.67%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_QtwZ0RanV0yILaQLjVfGaw_0_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:31.69%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityFileNumber" id="Tc_c6WybimHY06YdB0A31u2zg_0_2"><b style="font-weight:bold;">001-39319</b></ix:nonNumeric></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:31.69%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityTaxIdentificationNumber" id="Tc_iwXw328SCEOsniMR-RSJTQ_0_4"><b style="font-weight:bold;">81-4301284</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:31.67%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(State or Other Jurisdiction</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of Incorporation)</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.69%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(Commission</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">File Number)</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.69%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(IRS&#160;Employer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Identification&#160;No.)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_098be361_2b01_4924_8103_2a4b76abbace"></a><a id="Tc_dMQBzHSpSUCMQZwC5FcPNw_0_0"></a><a id="Tc_AMGkaHEATE-_9zEetoIkzg_1_0"></a><a id="Tc_E-b3xseP-EWknm5vIwJgyA_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0010261536%;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:48.77%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityAddressAddressLine1" id="Narr_ruNFY_BXb06v-DNvHwzrSg"><b style="font-weight:bold;">301 Binney Street</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityAddressCityOrTown" id="Narr_Cv8dmWU61kSvkxKJexVZQw"><b style="font-weight:bold;">Cambridge</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityAddressStateOrProvince" id="Narr_0pM4dca8Ikaa27ZLz5IIMA"><b style="font-weight:bold;">MA</b></ix:nonNumeric></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:48.76%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:EntityAddressPostalZipCode" id="Tc_NS7S2h_DIk6UXya3rUP5MA_0_2"><b style="font-weight:bold;">02142&#160;</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:48.77%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(Address of Principal Executive Offices)</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.46%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:48.76%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(Zip Code)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:CityAreaCode" id="Narr_58Ts0CABtkexJHN20Sc6kA"><b style="font-weight:bold;">617</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:LocalPhoneNumber" id="Narr_2Z-jjfz_TkSOMlGwfy401A"><b style="font-weight:bold;">655-7500</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Not applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">(Former Name or Former Address, if Changed Since Last Report)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:5.0pt;margin-bottom:5pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1.5pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i style="font-style:italic;">see</i> General Instruction A.2. below):</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 0pt 0.25pt;"><span style="display:inline-block;width:22.3pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_nXYQFNhpfkOyB5ebf8XcZw"><span style="font-family:'Segoe UI Symbol';font-size:12pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425) </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 0pt 0.25pt;"><span style="display:inline-block;width:22.3pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_ZNAJs0oaZEmYiXEEqCx8vg"><span style="font-family:'Segoe UI Symbol';font-size:12pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 0pt 0.25pt;"><span style="display:inline-block;width:22.3pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_1UwmuWXk6EiFHGU3Q9Tgkw"><span style="font-family:'Segoe UI Symbol';font-size:12pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 0pt 0.25pt;"><span style="display:inline-block;width:22.3pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_AuF7oPy8VUmO5DZ1lN_dcQ"><span style="font-family:'Segoe UI Symbol';font-size:12pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_99979441_6d9f_4790_b119_cc90bf772af3"></a><a id="Tc_Ol1zCNgI8kO0qmF2lXiCkQ_1_0"></a><a id="Tc_kS2GJS85iEqq2OBo1MFYqA_1_2"></a><a id="Tc_zfrG7QwV6U2ejxp-sHRe2w_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:31.99%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:31.99%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:32%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.99%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.99%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:Security12bTitle" id="Tc_iobY-aqUt0yNEWozTE0MUw_2_0"><b style="font-weight:bold;">Common Stock, $0.0001 par value per share</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" name="dei:TradingSymbol" id="Tc_2E4MDxAbVEKncuaSEdhLLA_2_2"><b style="font-weight:bold;">GBIO</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_mmpmkuj_PUORSSi1TfhHyA_2_4"><b style="font-weight:bold;">Nasdaq Global Select Market</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:80%;border:0;margin:30pt 10% 30pt 10%;"></div><div style="max-width:100%;padding-left:10%;padding-right:10%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 5pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;text-indent:0pt;margin:0pt 0pt 5pt 0pt;">Emerging growth company&#160;&#160;<ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_cz8F8tLaN06m8dgvK5INcw" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="Narr_jYecrCgK2UuWBcb1ML9Pww"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 5pt 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-bottom:1pt;padding-top:1pt;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:80%;border:0;margin:30pt 10% 30pt 10%;"></div><div style="max-width:100%;padding-left:10%;padding-right:10%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_d92cfa8a_bf10_42d1_a07b_468c276f2d57"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Item&#160;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-top:6pt;text-align:justify;background:#ffffff;margin:0pt;">On February 4, 2022, the Board of Directors of Generation Bio Co., or the Company, appointed Antoinette Paone, M.S., MBA, as Chief Operating Officer of the Company, effective as of February 10, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-top:6pt;text-align:justify;background:#ffffff;margin:0pt;">Prior to being appointed as the Company&#8217;s Chief Operating Officer, Ms. Paone, age 44, served as the Company&#8217;s Senior Vice President, Regulatory and Quality, from February 2020 to February 2022 and its Vice President, Regulatory Affairs from October 2018 to February 2020. Before joining the Company, Ms. Paone served as Vertex Pharmaceuticals, Inc.&#8217;s Vice President of Global Regulatory Affairs from October 2013 to September 2017 and its Head of Regulatory Affairs CMC from October 2011 to September 2013. She received her B.S. in chemistry at Fordham University, her M.S. in organic chemistry at Yale University and her MBA from Bentley College.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-top:6pt;text-align:justify;background:#ffffff;margin:0pt;">In connection with her appointment as Chief Operating Officer, Ms. Paone&#8217;s annual base salary will be increased to $440,000 and her annual target bonus will be 40% of her annual base salary, prorated for 2022. The Company will also grant Ms. Paone an option to purchase 110,000 shares of the Company&#8217;s common stock under the Company&#8217;s 2020 Stock Incentive Plan. The option will have an exercise price equal to the closing price of the Company&#8217;s common stock on the Nasdaq Global Select Market on February 10, 2022, and a term of 10 years. The option will vest as to 25% of the shares underlying the option on February 10, 2023 and as to an additional 6.25% of the underlying shares quarterly thereafter until February 10, 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-top:6pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-top:6pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:80%;border:0;margin:30pt 10% 30pt 10%;"></div><div style="max-width:100%;padding-left:10%;padding-right:10%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_9229c5a0_6d90_42df_88de_7d238d1fe43f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:99.26%;"><tr><td style="vertical-align:top;width:49.67%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.32%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">GENERATION BIO CO.</p></td></tr><tr><td style="vertical-align:top;width:49.67%;margin:0pt;padding:0.25pt;"></td><td colspan="2" style="vertical-align:bottom;width:50.32%;margin:0pt;padding:0.25pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.67%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">Date: February 10, 2022</p></td><td style="vertical-align:bottom;width:4.51%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.81%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">/s/ Geoff McDonough</p></td></tr><tr><td style="vertical-align:top;width:49.67%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:bottom;width:4.51%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:bottom;width:45.81%;border-top:1px solid #000000;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">Name: Geoff McDonough, M.D.</p></td></tr><tr><td style="vertical-align:top;width:49.67%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:bottom;width:4.51%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:bottom;width:45.81%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">Title: President and Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10%;margin-right:10%;margin-top:30pt;page-break-after:avoid;width:80%;border:0;"></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "gbio-20220204x8k.htm", "description": "8-K", "secsgml_size_bytes": 33990}]
{"company-data": {"conformed-name": "Generation Bio Co.", "cik": "0001733294", "assigned-sic": "2834", "irs-number": "814301281", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-39319", "film-number": "22609592"}, "business-address": {"street1": "301 BINNEY STREET", "city": "CAMBRIDGE", "state": "MA", "zip": "02142", "phone": "857-529-5908"}, "mail-address": {"street1": "301 BINNEY STREET", "city": "CAMBRIDGE", "state": "MA", "zip": "02142"}}
​
​
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
February 4, 2022
Generation Bio Co.
(Exact Name of Registrant as Specified in Charter)
​
Delaware
001-39319
81-4301284
(State or Other Jurisdiction
of Incorporation)
​
(Commission
File Number)
​
(IRS Employer
Identification No.)
​
​
301 Binney Street
Cambridge
,
MA
02142
(Address of Principal Executive Offices)
​
(Zip Code)
​
Registrant's telephone number, including area code: (
617
)
655-7500
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
​
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
​
​
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
​
​
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
​
​
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
​
Securities registered pursuant to Section 12(b) of the Act:
​
​
​
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
​
GBIO
​
Nasdaq Global Select Market
​
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
​
​
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On February 4, 2022, the Board of Directors of Generation Bio Co., or the Company, appointed Antoinette Paone, M.S., MBA, as Chief Operating Officer of the Company, effective as of February 10, 2022.
Prior to being appointed as the Company's Chief Operating Officer, Ms. Paone, age 44, served as the Company's Senior Vice President, Regulatory and Quality, from February 2020 to February 2022 and its Vice President, Regulatory Affairs from October 2018 to February 2020. Before joining the Company, Ms. Paone served as Vertex Pharmaceuticals, Inc.'s Vice President of Global Regulatory Affairs from October 2013 to September 2017 and its Head of Regulatory Affairs CMC from October 2011 to September 2013. She received her B.S. in chemistry at Fordham University, her M.S. in organic chemistry at Yale University and her MBA from Bentley College.
In connection with her appointment as Chief Operating Officer, Ms. Paone's annual base salary will be increased to $440,000 and her annual target bonus will be 40% of her annual base salary, prorated for 2022. The Company will also grant Ms. Paone an option to purchase 110,000 shares of the Company's common stock under the Company's 2020 Stock Incentive Plan. The option will have an exercise price equal to the closing price of the Company's common stock on the Nasdaq Global Select Market on February 10, 2022, and a term of 10 years. The option will vest as to 25% of the shares underlying the option on February 10, 2023 and as to an additional 6.25% of the underlying shares quarterly thereafter until February 10, 2026.
​
​
​
​
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
​
GENERATION BIO CO.
Date: February 10, 2022
By:
/s/ Geoff McDonough
Name: Geoff McDonough, M.D.
Title: President and Chief Executive Officer
​
​
​